CALR

Paola Guglielmelli1, Natasha Szuber2,3,4, Naseema Gangat5

  • 1Department of Experimental and Clinical Medicine, Center of Research and Innovation of Myeloproliferative Neoplasms, Division of Hematology, Azienda Ospedaliera Universitaria Careggi, Florence, Italy.

Blood
|January 22, 2024
PubMed
概括

高变异性等位基因频率 (≥60%) 在卡尔雷蒂库林 (CALR) 突变中与在没有骨髓纤维化的情况下更短的存活时间有关. 这种关联特别适用于CALR类型-1和不确定的突变.